1Cohen A,Hirschhorn R,Horowitz SD,et al.Deoxyadenosine triphosphate as a potentially toxic metabolite in adenosine deaminase deficiency.Proc Natl Acad Sci USA,1978,75(1):472-476.
2Carson DA, Wasson DB, Kaye J, et al. Deoxycytidine kinase-mediated toxicity of deoxyadenosine analogs toward malignant human lymphoblasts in vitro and toward murine L1210 leukemia in vivo.Proc Natl Acad Sci USA,1980,77(11):6865-6869.
3Sigal DS,Miller HJ, Schram ED,et al.Beyond hairy cell: the activity of cladribine in other hematologic malignancies.Blood,2010,11616):2884 -2896.
4Torrey ML, Sigal DS, Saven A.Development of cladribine at Scripps for hairy cell leukemia and current results.Leuk Lymphoma,2011,52(2):29-33.
5Robak T, Jamroziak K,Gora-Tybor J,et al.Cladribine in a weekly versus daily schedule for untreated active hairy cell leukemia: final report from the Polish Adult Leukemia Group (PALG) of a pmspective,ra ndomized,multicenter trisl.Blood,2007,109(9):3672-3675.
6Tallman MS,Zakarija A.Hairy cell leukemia: survival and relapse.Long-term follow-up of purine anaiog-based therapy and approach for relapsed disease. Transfus Apher Sci,2005,32(1): 99-103.
7Goodman GR,Burian C,Koziol JA,et al. Extended follow-up of patients with hairy cell leukemia after treatment with cladribine.J Clin Oncol,2003,21(5): 891-896.
8Seymour JF, Kurzrock R,Freireich EJ,et al.2- chlorodeoxyadenosine induces durable remissions and prolonged suppression of CD4+ lymphocyte counts in patients with hairy cell leukemia.Blood, 1994,83(10):2906- 2911.
9Tadmor T.Purine analog toxicity in patients with hairy cell leukemia.Leuk Lymphoma,2011,52 (Suppl 2):38-42.
10Else M,Dearden CE,Matutes E,et ai.Long-term follow-up of 233 patients with hairy cell leukaemia,treated initially with pentostatin or cladribine,at a median of 16 years from diagnosis.Br J Haematol, 2009,145(6):733-740.
